BHA issue notice, regarding Regumate Equine, to British racehorse Trainers
On 11 September the BHA published a Notice regarding the use of products which contain altrenogest – a copy of this notice can be found on the BHA website.
At the time of publication, the BHA obtained samples from several different batch numbers of Regumate® Equine 2.2mg/ml Oral Solution for Horses (MSD Animal Health) and requested analysis of these samples from LGC, our partner analytical laboratory. The results of this analysis detected the presence of trendione in the above batches of Regumate® Equine.
British Horseracing Authority Notice regarding use of Altrenogest
The BHA would like to make Trainers, veterinary surgeons and other industry participants aware of an international issue regarding products which contain altrenogest. Altrenogest is commonly referred to by the trade name “Regumate”.